Function of mucosa-associated lymphoid tissue in antibody formation.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 20450282)

Published in Immunol Invest on January 01, 2010

Authors

Per Brandtzaeg1

Author Affiliations

1: Laboratory for Immunohistochemistry and Immunopathology (LIIPAT), Centre for Immune Regulation, University of Oslo, Department and Institute of Pathology, Oslo University Hospital, Rikshospitalet, N-0027 Oslo, Norway. per.brandtzaeg@medisin.uio.no

Articles citing this

Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol (2012) 2.65

The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol (2011) 2.29

Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol (2011) 2.26

Leukocytes in mammary development and cancer. Cold Spring Harb Perspect Biol (2011) 1.88

B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma. Clin Cancer Res (2013) 1.60

Mucosal immunoglobulins and B cells of teleost fish. Dev Comp Immunol (2011) 1.28

Secretory IgA: Designed for Anti-Microbial Defense. Front Immunol (2013) 1.27

Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy. J Clin Invest (2011) 1.22

Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. Arthritis Rheum (2013) 1.08

Food allergy: separating the science from the mythology. Nat Rev Gastroenterol Hepatol (2010) 1.06

Inside the mucosal immune system. PLoS Biol (2012) 1.03

The tonsils revisited: review of the anatomical localization and histological characteristics of the tonsils of domestic and laboratory animals. Clin Dev Immunol (2011) 0.98

Secretory immunity with special reference to the oral cavity. J Oral Microbiol (2013) 0.96

Which Antibody Functions are Important for an HIV Vaccine? Front Immunol (2014) 0.94

Mucosal immunization with recombinant fusion protein DnaJ-ΔA146Ply enhances cross-protective immunity against Streptococcus pneumoniae infection in mice via interleukin 17A. Infect Immun (2014) 0.87

IgA subclass switch recombination in human mucosal and systemic immune compartments. Mucosal Immunol (2013) 0.85

Microbe-dependent CD11b+ IgA+ plasma cells mediate robust early-phase intestinal IgA responses in mice. Nat Commun (2013) 0.84

The human intestinal IgA response; burning questions. Front Immunol (2012) 0.84

Faecal microbiome in new-onset juvenile idiopathic arthritis. Eur J Clin Microbiol Infect Dis (2015) 0.84

Gut microbiota-host interactions and juvenile idiopathic arthritis. Pediatr Rheumatol Online J (2016) 0.82

Development, alteration and real time dynamics of conjunctiva-associated lymphoid tissue. PLoS One (2013) 0.81

The SRC family tyrosine kinase HCK and the ETS family transcription factors SPIB and EHF regulate transcytosis across a human follicle-associated epithelium model. J Biol Chem (2013) 0.81

Shiga toxin-induced apoptosis is more efficiently inhibited by dimeric recombinant hybrid-IgG/IgA immunoglobulins than by the parental IgG monoclonal antibodies. Virulence (2014) 0.80

Alcaligenes is Commensal Bacteria Habituating in the Gut-Associated Lymphoid Tissue for the Regulation of Intestinal IgA Responses. Front Immunol (2012) 0.80

Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives. Pharmaceutics (2014) 0.78

Characterization of antigen-presenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxins. Mol Oral Microbiol (2011) 0.78

Flavonoids Affect Host-Microbiota Crosstalk through TLR Modulation. Antioxidants (Basel) (2014) 0.77

Expression Profile of Human Fc Receptors in Mucosal Tissue: Implications for Antibody-Dependent Cellular Effector Functions Targeting HIV-1 Transmission. PLoS One (2016) 0.76

Bordetella pertussis transmission. Pathog Dis (2015) 0.76

Strategies to avoid Shiga toxin effects. Virulence (2015) 0.75

Current prospects and future challenges for nasal vaccine delivery. Hum Vaccin Immunother (2016) 0.75